MC1R expression in HaCaT keratinocytes inhibits UVA-induced ROS production via NADPH Oxidase- and cAMP-dependent mechanisms

Journal of Cellular Physiology

Volumn 227, Issue 6, 2012, Pages 2578-2585

  Henri, Pauline ^a   Beaumel, Sylvain ^b   Guezennec, Anne ^c   Poumès, Carine ^c   Stoebner, Pierre Emmanuel ^a,d   Stasia, Marie José ^b   Guesnet, Joëlle ^c   Martinez, Jean ^a   Meunier, Laurent ^a,d  

^a UNIVERSITÉ DE MONTPELLIER   (France)

^b GRENOBLE UNIVERSITY HOSPITAL   (France)

^c Yves Saint Laurent Research and Development   (France)

^d DEPARTMENT OF NEUROLOGY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; MELANOCORTIN 1 RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; NOX ACTIVATOR 1 PROTEIN; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; UNCLASSIFIED DRUG;

ARTICLE; CELL METABOLISM; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; INTRACELLULAR SIGNALING; KERATINOCYTE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; ULTRAVIOLET A RADIATION; WILD TYPE;

ADAPTOR PROTEINS, VESICULAR TRANSPORT; ALPHA-MSH; CELL LINE; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; DOSE-RESPONSE RELATIONSHIP, RADIATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HUMANS; KERATINOCYTES; NADPH OXIDASE; OXIDATIVE STRESS; PHOSPHORYLATION; PROTEIN KINASE INHIBITORS; REACTIVE OXYGEN SPECIES; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR, MELANOCORTIN, TYPE 1; SIGNAL TRANSDUCTION; TIME FACTORS; TRANSFECTION; ULTRAVIOLET RAYS;

EID: 84857496831     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.22996     Document Type: Article

References (79)

1. Babior BM, Lambeth JD, Nauseef W. 2002. The neutrophil NADPH oxidase. Arch Biochem Biophys 397:342-344.
2. Barbier AJ, Poppleton HM, Yigzaw Y, Mullenix JB, Wiepz GJ, Bertics PJ, Patel TB. 1999. Transmodulation of epidermal growth factor receptor function by cyclic AMP-dependent protein kinase. J Biol Chem 274:14067-14073.
3. Batandier C, Fontaine E, Keriel C, Leverve XM. 2002. Determination of mitochondrial reactive oxygen species: Methodological aspects. J Cell Mol Med 6:175-187.
4. Bedard K, Krause KH. 2007. The NOX family of ROS-generating NADPH oxidases: Physiology and pathophysiology. Physiol Rev 87:245-313.
5. Bhola NE, Grandis JR. 2008. Crosstalk between G-protein-coupled receptors and epidermal growth factor receptor in cancer. Front Biosci 13:1857-1865.
6. Blenis J. 1993. Signal transduction via the MAP kinases: Proceed at your own RSK. Proc Natl Acad Sci USA 90:5889-5892.
7. Bohm M, Wolff I, Scholzen TE, Robinson SJ, Healy E, Luger TA, Schwarz T, Schwarz A. 2005. Alpha-melanocyte-stimulating hormone protects from ultraviolet radiation-induced apoptosis and DNA damage. J Biol Chem 280:5795-5802.
8. Box NF, Wyeth JR, O'Gorman LE, Martin NG, Sturm RA. 1997. Characterization of melanocyte stimulating hormone receptor variant alleles in twins with red hair. Hum Mol Genet 6:1891-1897.
9. Busca R, Ballotti R. 2000. Cyclic AMP a key messenger in the regulation of skin pigmentation. Pigment Cell Res 13:60-69.
10. Catania A, Gatti S, Colombo G, Lipton JM. 2004. Targeting melanocortin receptors as a novel strategy to control inflammation. Pharmacol Rev 56:1-29.
11. Chakraborty AK, Funasaka Y, Pawelek JM, Nagahama M, Ito A, Ichihashi M. 1999. Enhanced expression of melanocortin-1 receptor (MC1-R) in normal human keratinocytes during differentiation: Evidence for increased expression of POMC peptides near suprabasal layer of epidermis. J Invest Dermatol 112:853-860.
12. Chaturvedi V, Qin JZ, Denning MF, Choubey D, Diaz MO, Nickoloff BJ. 1999. Apoptosis in proliferating, senescent, and immortalized keratinocytes. J Biol Chem 274:23358-23367.
13. Chen W, Shang WH, Adachi Y, Hirose K, Ferrari DM, Kamata T. 2008. A possible biochemical link between NADPH oxidase (Nox) 1 redox-signalling and ERp72. Biochem J 416:55-63.
14. Crawford MA, Aylott CV, Bourdeau RW, Bokoch GM. 2006. Bacillus anthracis toxins inhibit human neutrophil NADPH oxidase activity. J Immunol 176:7557-7565.
15. Curry JL, Pinto W, Nickoloff BJ, Slominski AT. 2001. Human keratinocytes express functional alpha-MSH (MC1-R) receptors. In Vitro Cell Dev Biol Anim 37:234-236.
16. de Gruijl FR. 2000. Photocarcinogenesis: UVA vs UVB. Methods Enzymol 319:359-366.
17. Dessauer CW. 2009. Adenylyl cyclase-A-kinase anchoring protein complexes: The next dimension in cAMP signaling. Mol Pharmacol 76:935-941.
18. Drube S, Stirnweiss J, Valkova C, Liebmann C. 2006. Ligand-independent and EGF receptor-supported transactivation: Lessons from beta2-adrenergic receptor signalling. Cell Signal 18:1633-1646.
19. El-Benna J, Dang PM, Perianin A. 2010. Peptide-based inhibitors of the phagocyte NADPH oxidase. Biochem Pharmacol 80:778-785.
20. Elfakir A, Ezzedine K, Latreille J, Ambroisine L, Jdid R, Galan P, Hercberg S, Gruber F, Malvy D, Tschachler E, Guinot C. 2009. Functional MC1R-gene variants are associated with increased risk for severe photoaging of facial skin. J Invest Dermatol 130:1107-1115.
21. Engh RA, Girod A, Kinzel V, Huber R, Bossemeyer D. 1996. Crystal structures of catalytic subunit of cAMP-dependent protein kinase in complex with isoquinolinesulfonyl protein kinase inhibitors H7, H8, and H89. Structural implications for selectivity. J Biol Chem 271:26157-26164.
22. Fusenig NE, Boukamp P. 1998. Multiple stages and genetic alterations in immortalization, malignant transformation, and tumor progression of human skin keratinocytes. Mol Carcinog 23:144-158.
23. Gao J, Li J, Ma L. 2005. Regulation of EGF-induced ERK/MAPK activation and EGFR internalization by G protein-coupled receptor kinase 2. Acta Biochim Biophys Sin (Shanghai) 37:525-531.
24. Garcia-Borron JC, Sanchez-Laorden BL, Jimenez-Cervantes C. 2005. Melanocortin-1 receptor structure and functional regulation. Pigment Cell Res 18:393-410.
25. Garcin G, Douki T, Stoebner PE, Guesnet J, Guezennec A, Martinez J, Cadet J, Meunier L. 2007. Cell surface expression of melanocortin-1 receptor on HaCaT keratinocytes and alpha-melanocortin stimulation do not affect the formation and repair of UVB-induced DNA photoproducts. Photochem Photobiol Sci 6:585-593.
26. Garcin G, Le Gallic L, Stoebner PE, Guezennec A, Guesnet J, Lavabre-Bertrand T, Martinez J, Meunier L. 2009. Constitutive expression of MC1R in HaCaT keratinocytes inhibits basal and UVB-induced TNF-alpha production. Photochem Photobiol 85:1440-1450.
27. Gauuan PJ, Trova MP, Gregor-Boros L, Bocckino SB, Crapo JD, Day BJ. 2002. Superoxide dismutase mimetics: Synthesis and structure-activity relationship study of MnTBAP analogues. Bioorg Med Chem 10:3013-3021.
28. Gerits N, Kostenko S, Shiryaev A, Johannessen M, Moens U. 2008. Relations between the mitogen-activated protein kinase and the cAMP-dependent protein kinase pathways: Comradeship and hostility. Cell Signal 20:1592-1607.
29. Haycock JW, Rowe SJ, Cartledge S, Wyatt A, Ghanem G, Morandini R, Rennie IG, MacNeil S. 2000. Alpha-melanocyte-stimulating hormone reduces impact of proinflammatory cytokine and peroxide-generated oxidative stress on keratinocyte and melanoma cell lines. J Biol Chem 275:15629-15636.
30. Healy E, Flannagan N, Ray A, Todd C, Jackson IJ, Matthews JN, Birch-Machin MA, Rees JL. 2000. Melanocortin-1-receptor gene and sun sensitivity in individuals without red hair. Lancet 355:1072-1073.
31. Healy E, Jordan SA, Budd PS, Suffolk R, Rees JL, Jackson IJ. 2001. Functional variation of MC1R alleles from red-haired individuals. Hum Mol Genet 10:2397-2402.
32. Herraiz C, Jimenez-Cervantes C, Zanna P, Garcia-Borron JC. 2009. Melanocortin 1 receptor mutations impact differentially on signalling to the cAMP and the ERK mitogen-activated protein kinase pathways. FEBS Lett 583:3269-3274.
33. Herraiz C, Journe F, Abdel-Malek Z, Ghanem G, Jimenez-Cervantes C, Garcia-Borron JC. 2011. Signaling from the human melanocortin 1 receptor to ERK1 and ERK2 mitogen-activated protein kinases involves transactivation of cKIT. Mol Endocrinol 25:138-156.
34. Heumuller S, Wind S, Barbosa-Sicard E, Schmidt HH, Busse R, Schroder K, Brandes RP. 2008. Apocynin is not an inhibitor of vascular NADPH oxidases but an antioxidant. Hypertension 51:211-217.
35. Hunt G, Todd C, Cresswell JE, Thody AJ. 1994. Alpha-melanocyte stimulating hormone and its analogue Nle4DPhe7 alpha-MSH affect morphology, tyrosinase activity and melanogenesis in cultured human melanocytes. J Cell Sci 107:205-211.
36. Ichihashi M, Ueda M, Budiyanto A, Bito T, Oka M, Fukunaga M, Tsuru K, Horikawa T. 2003. UV-induced skin damage. Toxicology 189:21-39.
37. Im S, Moro O, Peng F, Medrano EE, Cornelius J, Babcock G, Nordlund JJ, Abdel-Malek ZA. 1998. Activation of the cyclic AMP pathway by alpha-melanotropin mediates the response of human melanocytes to ultraviolet B radiation. Cancer Res 58:47-54.
38. Kadekaro AL, Kanto H, Kavanagh R, Abdel-Malek ZA. 2003a. Significance of the melanocortin 1 receptor in regulating human melanocyte pigmentation, proliferation, and survival. Ann NY Acad Sci 994:359-365.
39. Kadekaro AL, Kavanagh RJ, Wakamatsu K, Ito S, Pipitone MA, Abdel-Malek ZA. 2003b. Cutaneous photobiology. The melanocyte vs. the sun: Who will win the final round? Pigment Cell Res 16:434-447.
40. Kadekaro AL, Kavanagh R, Kanto H, Terzieva S, Hauser J, Kobayashi N, Schwemberger S, Cornelius J, Babcock G, Shertzer HG, Scott G, Abdel-Malek ZA. 2005. alpha-Melanocortin and endothelin-1 activate antiapoptotic pathways and reduce DNA damage in human melanocytes. Cancer Res 65:4292-4299.
41. Kennedy C, ter Huurne J, Berkhout M, Gruis N, Bastiaens M, Bergman W, Willemze R, Bavinck JN. 2001. Melanocortin 1 receptor (MC1R) gene variants are associated with an increased risk for cutaneous melanoma which is largely independent of skin type and hair color. J Invest Dermatol 117:294-300.
42. Kim JS, Diebold BA, Babior BM, Knaus UG, Bokoch GM. 2007. Regulation of Nox1 activity via protein kinase A-mediated phosphorylation of NoxA1 and 14-3 binding. J Biol Chem 282:34787-34800.
43. Kroviarski Y, Debbabi M, Bachoual R, Perianin A, Gougerot-Pocidalo MA, El-Benna J, Dang PM. 2010. Phosphorylation of NADPH oxidase activator 1 (NOXA1) on serine 282 by MAP kinases and on serine 172 by protein kinase C and protein kinase A prevents NOX1 hyperactivation. FASEB J 24:2077-2092.
44. Kudin AP, Bimpong-Buta NY, Vielhaber S, Elger CE, Kunz WS. 2004. Characterization of superoxide-producing sites in isolated brain mitochondria. J Biol Chem 279:4127-4135.
45. Lambeth JD. 2004. NOX enzymes and the biology of reactive oxygen. Nat Rev Immunol 4:181-189.
46. Lewis DA, Hengeltraub SF, Gao FC, Leivant MA, Spandau DF. 2006. Aberrant NF-kappaB activity in HaCaT cells alters their response to UVB signaling. J Invest Dermatol 126:1885-1892.
47. Lin P, Welch EJ, Gao XP, Malik AB, Ye RD. 2005. Lysophosphatidylcholine modulates neutrophil oxidant production through elevation of cyclic AMP. J Immunol 174:2981-2989.
48. Lipton JM, Catania A. 1997. Anti-inflammatory actions of the neuroimmunomodulator alpha-MSH. Immunol Today 18:140-145.
49. Liu Y, Fiskum G, Schubert D. 2002. Generation of reactive oxygen species by the mitochondrial electron transport chain. J Neurochem 80:780-787.
50. Luger TA, Brzoska T, Scholzen TE, Kalden DH, Sunderkotter C, Armstrong C, Ansel J. 2000. The role of alpha-MSH as a modulator of cutaneous inflammation. Ann NY Acad Sci 917:232-238.
51. Luger TA, Scholzen TE, Brzoska T, Bohm M. 2003. New insights into the functions of alpha-MSH and related peptides in the immune system. Ann NY Acad Sci 994:133-140.
52. Marshall CJ. 1995. Specificity of receptor tyrosine kinase signaling: Transient versus sustained extracellular signal-regulated kinase activation. Cell 80:179-185.
53. Mukhopadhyay P, Rajesh M, Hasko G, Hawkins BJ, Madesh M, Pacher P. 2007a. Simultaneous detection of apoptosis and mitochondrial superoxide production in live cells by flow cytometry and confocal microscopy. Nat Protoc 2:2295-2301.
54. Mukhopadhyay P, Rajesh M, Yoshihiro K, Hasko G, Pacher P. 2007b. Simple quantitative detection of mitochondrial superoxide production in live cells. Biochem Biophys Res Commun 358:203-208.
55. Newton RA, Smit SE, Barnes CC, Pedley J, Parsons PG, Sturm RA. 2005. Activation of the cAMP pathway by variant human MC1R alleles expressed in HEK and in melanoma cells. Peptides 26:1818-1824.
56. Newton RA, Roberts DW, Leonard JH, Sturm RA. 2007. Human melanocytes expressing MC1R variant alleles show impaired activation of multiple signaling pathways. Peptides 28:2387-2396.
57. Nishigori C. 2006. Cellular aspects of photocarcinogenesis. Photochem Photobiol Sci 5:208-214.
58. Oh H, Jung HY, Kim J, Bae YS. 2010. Phosphorylation of serine282 in NADPH oxidase activator 1 by Erk desensitizes EGF-induced ROS generation. Biochem Biophys Res Commun 394:691-696.
59. Oktar BK, Yuksel M, Alican I. 2004. The role of cyclooxygenase inhibition in the effect of alpha-melanocyte-stimulating hormone on reactive oxygen species production by rat peritoneal neutrophils. Prostaglandins Leukot Essent Fatty Acids 71:1-5.
60. Palmer JS, Duffy DL, Box NF, Aitken JF, O'Gorman LE, Green AC, Hayward NK, Martin NG, Sturm RA. 2000. Melanocortin-1 receptor polymorphisms and risk of melanoma: Is the association explained solely by pigmentation phenotype? Am J Hum Genet 66:176-186.
61. Qin JZ, Chaturvedi V, Denning MF, Choubey D, Diaz MO, Nickoloff BJ. 1999. Role of NF-kappaB in the apoptotic-resistant phenotype of keratinocytes. J Biol Chem 274:37957-37964.
62. Rees JL. 2004. The genetics of sun sensitivity in humans. Am J Hum Genet 75:739-751.
63. Rey FE, Cifuentes ME, Kiarash A, Quinn MT, Pagano PJ. 2001. Novel competitive inhibitor of NAD(P)H oxidase assembly attenuates vascular O(2)(-) and systolic blood pressure in mice. Circ Res 89:408-414.
64. Ringholm A, Klovins J, Rudzish R, Phillips S, Rees JL, Schioth HB. 2004. Pharmacological characterization of loss of function mutations of the human melanocortin 1 receptor that are associated with red hair. J Invest Dermatol 123:917-923.
65. Roberts DW, Newton RA, Beaumont KA, Helen Leonard J, Sturm RA. 2006. Quantitative analysis of MC1R gene expression in human skin cell cultures. Pigment Cell Res 19:76-89.
66. Robinson S, Dixon S, August S, Diffey B, Wakamatsu K, Ito S, Friedmann PS, Healy E. 2010. Protection against UVR involves MC1R-mediated non-pigmentary and pigmentary mechanisms in vivo. J Invest Dermatol 130:1904-1913.
67. Rozengurt E. 2007. Mitogenic signaling pathways induced by G protein-coupled receptors. J Cell Physiol 213:589-602.
68. Sanchez-Laorden BL, Jimenez-Cervantes C, Garcia-Borron JC. 2007. Regulation of human melanocortin 1 receptor signaling and trafficking by Thr-308 and Ser-316 and its alteration in variant alleles associated with red hair and skin cancer. J Biol Chem 282:3241-3251.
69. Sanchez-Mas J, Hahmann C, Gerritsen I, Garcia-Borron JC, Jimenez-Cervantes C. 2004. Agonist-independent, high constitutive activity of the human melanocortin 1 receptor. Pigment Cell Res 17:386-395.
70. Sarkar A, Sreenivasan Y, Manna SK. 2003. Alpha-melanocyte-stimulating hormone inhibits lipopolysaccharide-induced biological responses by downregulating CD14 from macrophages. FEBS Lett 553:286-294.
71. Schiller M, Brzoska T, Bohm M, Metze D, Scholzen TE, Rougier A, Luger TA. 2004. Solar-simulated ultraviolet radiation-induced upregulation of the melanocortin-1 receptor, proopiomelanocortin, and alpha-melanocyte-stimulating hormone in human epidermis in vivo. J Invest Dermatol 122:468-476.
72. Skroblin P, Grossmann S, Schafer G, Rosenthal W, Klussmann E. 2010. Mechanisms of protein kinase a anchoring. Int Rev Cell Mol Biol 283:235-330.
73. Slominski A, Wortsman J, Luger T, Paus R, Solomon S. 2000. Corticotropin releasing hormone and proopiomelanocortin involvement in the cutaneous response to stress. Physiol Rev 80:979-1020.
74. Song X, Mosby N, Yang J, Xu A, Abdel-Malek Z, Kadekaro AL. 2009. alpha-MSH activates immediate defense responses to UV-induced oxidative stress in human melanocytes. Pigment Cell Melanoma Res 22:809-818.
75. Soufir N, Grandchamp B, Basset-Seguin N. 2009. New trends in the susceptibility to melanoma. Cancer Treat Res 146:213-223.
76. Stork PJ, Schmitt JM. 2002. Crosstalk between cAMP and MAP kinase signaling in the regulation of cell proliferation. Trends Cell Biol 12:258-266.
77. Sturm RA, Duffy DL, Box NF, Newton RA, Shepherd AG, Chen W, Marks LH, Leonard JH, Martin NG. 2003. Genetic association and cellular function of MC1R variant alleles in human pigmentation. Ann NY Acad Sci 994:348-358.
78. Valencia A, Kochevar IE. 2008. Nox1-based NADPH oxidase is the major source of UVA-induced reactive oxygen species in human keratinocytes. J Invest Dermatol 128:214-222.
79. Valverde P, Healy E, Jackson I, Rees JL, Thody AJ. 1995. Variants of the melanocyte-stimulating hormone receptor gene are associated with red hair and fair skin in humans. Nat Genet 11:328-330.